Tadashi Fujisawa

Abstract C36: MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/II study in gastro-esophageal adenocarcinoma, with pharmacokinetics

Neil Senzer, Kazuhiko Matsuno, N. Yamagata et al. · Molecular Cancer Therapeutics · 2009 · 40 citations

Pharmacy, Oncology, Pharmacology +15

Preparation of Superconducting Y–Ba–Cu–O and Bi–Pb–Sr–Ca–Cu–O Compounds by Chelating Method

Tadashi Fujisawa, Akira Takagi, Tetzuji Honjo et al. · Japanese Journal of Applied Physics · 1989 · 21 citations

Natural Sciences, Chemistry, Materials Science +17

Solvent Effects on the ESR Spectra of Copper(II) Complexes. A Consideration of the Donicity of Water and Methanol

Tateaki Ogata, Tadashi Fujisawa, Nobuyuki Tanaka et al. · Bulletin of the Chemical Society of Japan · 1976 · 20 citations · Full text

Natural Sciences, Chemistry, Analytical Chemistry +16

Electrochemical Properties of Ferrocenophanes. I. Voltammetric Studies on the Oxidation of Mono-, Di-, and Tri-bridged Ferrocenophanes in Acetonitrile

Tateaki Ogata, Kazuo Oikawa, Tadashi Fujisawa et al. · Bulletin of the Chemical Society of Japan · 1981 · 19 citations · Full text

Natural Sciences, Chemistry, Electroanalytical Methods +12

Open label phase I study of MBP-426, a novel formulation of oxaliplatin, in patients with advanced or metastatic solid tumors.

Alexandria T. Phan, Chris H. Takimoto, Rosni Adinin et al. · Molecular Cancer Therapeutics · 2007 · 11 citations

Pharmacy, Pharmacokinetics, Pharmacology +17